Injective price prediction: Can sellers regain control? INJ gains 8.18% near resistance

Traders Union
All News
Crypto News
Injective surges 8.18% today to $4.58

Highlights

Injective (INJ) trades at $4.58, remaining below MA-20 ($4.70), MA-50 ($5.42), and MA-200 ($10.25), confirming sustained bearish pressure across all timeframes.
Technical indicators show negative momentum: MACD signals bearishness, RSI is 41.93, Stochastic RSI is overbought at 80.69, and CCI is bearish at –99.21.
For the next five trading days, price is expected to consolidate between $4.35 and $4.80, with a less than 20% chance of a bullish breakout.

Conflicting momentum as sellers lead but intraday strength emerges

Momentum indicators on the daily timeframe remain negative, with MACD signaling strong bearish momentum and ADX at 31.20 reflecting reasonably strong trend persistence. RSI sits at 41.93, accompanied by a Stochastic RSI of 80.69 (overbought) and a bearish CCI at –99.21, highlighting minor divergence and suggesting caution as price rebounds from intraday lows. BBP also points to seller dominance, while the Awesome Oscillator is currently neutral and does not reinforce the overall trend. There was a modest gap up at today’s open ($4.54 vs. prior close $4.23), and price action currently trades near the top of today's range ($4.51 – $4.64). Volatility has been moderate to high, and the intraday tone has favored strength toward the highs, even as momentum remains conflicted.

Sideways consolidation likely as upside probability remains low

For the coming five trading days, the expected price range is adjusted to $4.35 – $4.80 to account for current volatility. The probability of further price increases is very low (less than 20%), making a pullback or correction more likely in the short term. The baseline scenario is sideways consolidation within the $4.35 – $4.80 band. A bullish breakout would require a firm close above $4.80, shifting focus toward the $5.18 resistance. A bearish scenario is signaled by a fall below $4.35, which could open the path to further downside, considering the prevailing negative momentum on higher timeframes.

Anton Kharitonov, expert at Traders Union, sees Injective (INJ) entrenched in a technical downtrend with persistent bearish momentum. He notes that all major averages and indicators point to continued risk of correction rather than sustained recovery. Kharitonov is cautious given the seller dominance and low odds for upside in the short term. "Base case remains sideways between $4.35 – $4.80 — until $4.80 breaks, I stay defensive."

Previously it was reported that Injective remains under persistent selling pressure, trading below its key moving averages, with technical indicators such as MACD, ADX, RSI, and CCI all signaling entrenched bearish momentum and oversold conditions. Immediate resistance is seen at the Ichimoku Kijun with support near recent lows, and the price is likely to consolidate within a narrow range barring a decisive break above resistance or below support.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.